Published by Josh White on 27th September 2024
(Sharecast News) - ValiRx, a life science company focussed on cancer therapeutic development, reported a total comprehensive loss of £0.97m for the six months ended 30 June on Friday, narrowing from a loss of £1.04m in the same period last year.
URL: http://www.digitallook.com/dl/news/story/34585299/...